A case of early gastric cancer that changed morphologically after Helicobacter pylori eradication therapy

2016 ◽  
Vol 88 (1) ◽  
pp. 98-99
Author(s):  
Yurika Ikegami ◽  
Tomoyuki Yada ◽  
Koichi Ito ◽  
Naomi Uemura
2009 ◽  
Vol 75 (2) ◽  
pp. 68-69
Author(s):  
Kyouhei Ooyama ◽  
Akitake Uno ◽  
Noriko Nakajima ◽  
Hisako Abe ◽  
Shun Kobayashi ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 1779
Author(s):  
Masaki Katsurahara ◽  
Ichiro Imoto ◽  
Yuhei Umeda ◽  
Hiroshi Miura ◽  
Junya Tsuboi ◽  
...  

Background: The role of Helicobacter pylori in the pathogenesis of reflux esophagitis is controversial. This study investigated the frequency of reflux esophagitis before and after H. pylori eradication in patients having endoscopic submucosal dissection for early gastric cancer. Methods: This study included 160 patients that fulfilled the study’s criteria. Endoscopy was performed before and after H. pylori eradication, and reflux esophagitis was evaluated during the follow-up period. Results: Seropositivity for H. pylori in patients with early gastric cancer was 68.8%, 101 of them received eradication therapy. During the follow-up period, the incidence of reflux esophagitis increased from 3.1% to 18.8% in the successful eradication group but no case of reflux esophagitis was observed in the failed eradication group. The univariate and multivariate analyses showed a significant correlation between successful H. pylori eradication rate and the development of reflux esophagitis. Conclusions: This study demonstrated that a successful H. pylori eradication therapy is a risk factor for newly developed reflux esophagitis in patients with endoscopic submucosal dissection for early gastric cancer.


Digestion ◽  
2021 ◽  
pp. 1-8
Author(s):  
Satoki Shichijo ◽  
Noriya Uedo ◽  
Tomoki Michida

<b><i>Background:</i></b> Based on evidence that <i>Helicobacter pylori</i> eradication reduces the development of gastric cancer and other diseases such as peptic ulcer, eradication therapy has prevailed. However, gastric cancer can develop even after successful eradication. <b><i>Summary:</i></b> In this review article, we searched for studies that identified the characteristics of primary and metachronous gastric cancers after <i>H. pylori</i> eradication, the risk factors for the development of these cancers after successful <i>H. pylori</i> eradication, and whether image-enhanced endoscopy is useful for diagnosing gastric cancer after eradication. A gastritis-like appearance is seen as a characteristic endoscopic finding, which corresponds to an epithelium with low-grade atypia – also known as nonneoplastic epithelium – covering the surface of the cancerous glands. This finding may make endoscopic detection of early gastric cancer difficult after <i>H. pylori</i> eradication. Similar risk factors, such as the male sex, endoscopic atrophy, histologic intestinal metaplasia, and late eradication, have been reported as predictors for the development of both primary and metachronous gastric cancers. Image-enhanced endoscopy, such as linked color imaging, may be useful for the detection and risk stratification of gastric cancer after eradication. <b><i>Key Messages:</i></b> Based on these findings, we believe that effective surveillance of high-risk patients leads to early detection of gastric cancer in the era of <i>H. pylori</i> eradication.


2001 ◽  
Vol 120 (5) ◽  
pp. A658-A658
Author(s):  
E UMEGAKI ◽  
M TANAKA ◽  
N TAKEUCHI ◽  
K NISHIMURA ◽  
M NANRI ◽  
...  

2007 ◽  
Vol 69 (1) ◽  
pp. 8-10
Author(s):  
Ritsuko KANO ◽  
Yusuke YOSHIZAWA ◽  
Seiji KAWANA ◽  
Taku TSUKUI

Sign in / Sign up

Export Citation Format

Share Document